306 related articles for article (PubMed ID: 17323126)
21. Nucleoside anticancer drugs: the role of nucleoside transporters in resistance to cancer chemotherapy.
Damaraju VL; Damaraju S; Young JD; Baldwin SA; Mackey J; Sawyer MB; Cass CE
Oncogene; 2003 Oct; 22(47):7524-36. PubMed ID: 14576856
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics/genomics and personalized medicine.
Sadée W; Dai Z
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
[TBL] [Abstract][Full Text] [Related]
23. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.
Cascorbi I
Pharmacol Ther; 2006 Nov; 112(2):457-73. PubMed ID: 16766035
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity.
Jabir RS; Naidu R; Annuar MA; Ho GF; Munisamy M; Stanslas J
Pharmacogenomics; 2012 Dec; 13(16):1979-88. PubMed ID: 23215890
[TBL] [Abstract][Full Text] [Related]
25. Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2).
Gradhand U; Kim RB
Drug Metab Rev; 2008; 40(2):317-54. PubMed ID: 18464048
[TBL] [Abstract][Full Text] [Related]
26. SLC22 transporter family proteins as targets for cytostatic uptake into tumor cells.
Gupta S; Burckhardt G; Hagos Y
Biol Chem; 2011 Jan; 392(1-2):117-24. PubMed ID: 21194368
[TBL] [Abstract][Full Text] [Related]
27. Pharmacogenetics of drug transporters in the enterohepatic circulation.
Stieger B; Meier PJ
Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
[TBL] [Abstract][Full Text] [Related]
28. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
Deeken JF; Figg WD; Bates SE; Sparreboom A
Anticancer Drugs; 2007 Feb; 18(2):111-26. PubMed ID: 17159598
[TBL] [Abstract][Full Text] [Related]
29. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
Smith L; Lind MJ; Welham KJ; Cawkwell L;
Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
[TBL] [Abstract][Full Text] [Related]
30. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
Joyce H; McCann A; Clynes M; Larkin A
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in the pharmacogenetics of cancer chemotherapy.
Watters JW; McLeod HL
Curr Opin Mol Ther; 2002 Dec; 4(6):565-71. PubMed ID: 12596358
[TBL] [Abstract][Full Text] [Related]
32. Importance of ABCC1 for cancer therapy and prognosis.
Kunická T; Souček P
Drug Metab Rev; 2014 Aug; 46(3):325-42. PubMed ID: 24670052
[TBL] [Abstract][Full Text] [Related]
33. Predicting drug response and toxicity based on gene polymorphisms.
Robert J; Morvan VL; Smith D; Pourquier P; Bonnet J
Crit Rev Oncol Hematol; 2005 Jun; 54(3):171-96. PubMed ID: 15890268
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of membrane transporters: an update on current approaches.
Sissung TM; Baum CE; Kirkland CT; Gao R; Gardner ER; Figg WD
Mol Biotechnol; 2010 Feb; 44(2):152-67. PubMed ID: 19950006
[TBL] [Abstract][Full Text] [Related]
35. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs.
Rodrigues AC; Hirata MH; Hirata RD
Pharmacogenomics; 2009 Jun; 10(6):1007-16. PubMed ID: 19530968
[TBL] [Abstract][Full Text] [Related]
36. Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.
Robert J
J Chemother; 2004 Nov; 16 Suppl 4():22-4. PubMed ID: 15688604
[TBL] [Abstract][Full Text] [Related]
37. Transporters and their impact on drug disposition.
Beringer PM; Slaughter RL
Ann Pharmacother; 2005 Jun; 39(6):1097-108. PubMed ID: 15886292
[TBL] [Abstract][Full Text] [Related]
38. Genetic variations and gene expression of transporters in drug disposition and response.
Huang Y; Penchala S; Pham AN; Wang J
Expert Opin Drug Metab Toxicol; 2008 Mar; 4(3):237-54. PubMed ID: 18363540
[TBL] [Abstract][Full Text] [Related]
39. Role of solute carrier transporters in pancreatic cancer: a review.
Lemstrová R; Souček P; Melichar B; Mohelnikova-Duchonova B
Pharmacogenomics; 2014 Jun; 15(8):1133-45. PubMed ID: 25084206
[TBL] [Abstract][Full Text] [Related]
40. Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition.
Bleasby K; Castle JC; Roberts CJ; Cheng C; Bailey WJ; Sina JF; Kulkarni AV; Hafey MJ; Evers R; Johnson JM; Ulrich RG; Slatter JG
Xenobiotica; 2006; 36(10-11):963-88. PubMed ID: 17118916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
